Assessment of Oxygen Pulse in Hypertrophic Cardiomyopathy-Reply

Matthew T Wheeler¹, Yu-Mao Chen², Jonathan Myers^{3

4}

Affiliations

¹ Division of Cardiovascular Medicine, Department of Medicine, Stanford University School of Medicine, Stanford, California.
² Bristol Myers Squibb, Princeton, New Jersey.
³ Veterans Affairs Palo Alto Health Care System, Palo Alto, California.
⁴ Stanford University, Stanford, California.

Comment

Matthew T Wheeler et al. JAMA Cardiol. 2023.

. 2023 Aug 1;8(8):796-797.

doi: 10.1001/jamacardio.2023.1889.

Matthew T Wheeler¹, Yu-Mao Chen², Jonathan Myers^{3

4}

¹ Division of Cardiovascular Medicine, Department of Medicine, Stanford University School of Medicine, Stanford, California.
² Bristol Myers Squibb, Princeton, New Jersey.
³ Veterans Affairs Palo Alto Health Care System, Palo Alto, California.
⁴ Stanford University, Stanford, California.

No abstract available

Comment on

Effects of Mavacamten on Measures of Cardiopulmonary Exercise Testing Beyond Peak Oxygen Consumption: A Secondary Analysis of the EXPLORER-HCM Randomized Trial.
Wheeler MT, Olivotto I, Elliott PM, Saberi S, Owens AT, Maurer MS, Masri A, Sehnert AJ, Edelberg JM, Chen YM, Florea V, Malhotra R, Wang A, Oreziak A, Myers J. Wheeler MT, et al. JAMA Cardiol. 2023 Mar 1;8(3):240-247. doi: 10.1001/jamacardio.2022.5099. JAMA Cardiol. 2023. PMID: 36652223 Free PMC article. Clinical Trial.
Assessment of Oxygen Pulse in Hypertrophic Cardiomyopathy.
van der Stouwe JG, Schmied CM, Niederseer D. van der Stouwe JG, et al. JAMA Cardiol. 2023 Aug 1;8(8):795-796. doi: 10.1001/jamacardio.2023.1886. JAMA Cardiol. 2023. PMID: 37405753 No abstract available.